Investors and Partners
Vaccitech is a private limited company with multiple investors.
Vaccitech continues to develop its clinical programs to treat and prevent infectious diseases and cancer through key milestones.
Vaccitech seeks and is open to forming industry collaborations and partnerships on its programs and to license its platform technology to target new indications.
We have also entered into non-exclusive licensure of our T-cell induction platform in oncology, and are committed to advancing the use of our platform for oncology in combination with checkpoint inhibitors.
Formed in 2005, Sequoia Capital China has an impressive and diverse portfolio that delivers high returns on investment using differentiated technologies and innovative business models. They have offices in Hong Kong, Beijing, Shanghai, Guangzhou, Hangzhou, Suzhou and Shenzhen.
Founded in 2000, GeneMatrix is a KOSDAQ listed company that uses clinical data to improve human health and welfare. The company has developed theranostic solutions for health problems to become the Korean market leader for HBV, HCV, HIV, and Human Papilloma Virus genotyping.
Established in 2002, Neptune is a UK-based fund management company established offering a range of ISA-friendly equity funds to private investors, advisers and institutional clients. The hallmark of each fund is pure active investment management executed with conviction.
Korea Investment Partners is a leading global venture capital & private equity firm with over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. They have offices in Seoul,Shanghai, Beijing, and Sunnyvale.
Launched as Google Ventures in 2009, GV is the venture capital arm of Alphabet, Inc. GV invested in more than 300 companies in the fields of life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture. GV companies aim to improve lives and change industries.